Achieve Life Sciences holder Dialectic to engage ‘more actively’

In a regulatory filing Friday, Dialectic Capital Management and John Fichthorn reported a 19.8% stake in Achieve Life Sciences and stated: "As one of the largest stockholders of the [company], the Reporting Persons have been closely monitoring developments at the [company] and intend to more actively engage in discussions with management and the Board of Directors regarding suggestions aimed at improving the performance, governance and compensation plans of the Issuer, including representation on the Board." Reference Link